High prevalence of fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric unit in Madagascar

被引:71
作者
Andriatahina, Todisoa [2 ]
Randrianirina, Frederique [1 ]
Hariniana, Eliosa Ratsima [1 ]
Talarmin, Antoine [1 ]
Raobijaona, Honore [2 ]
Buisson, Yves [3 ]
Richard, Vincent [1 ]
机构
[1] Inst Pasteur, Antananarivo, Madagascar
[2] Hop Joseph Raseta Befelatanana, Antananarivo, Madagascar
[3] Inst Francophonie Med Trop, Ventiane, Laos
关键词
INTENSIVE-CARE-UNIT; GRAM-NEGATIVE BACTERIA; ANTIMICROBIAL RESISTANCE; ENTEROBACTERIACEAE; COLONIZATION; EPIDEMIOLOGY; INFECTIONS; OUTBREAK; SPREAD; PATHOGENS;
D O I
10.1186/1471-2334-10-204
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae have spread worldwide but there are few reports on carriage in hospitals in low-income countries. ESBL-producing Enterobacteriaceae (ESBL-PE) have been increasingly isolated from nosocomial infections in Antananarivo, Madagascar. Methods: we conducted a prevalence survey in a pediatric unit from March to April 2008 Patient rectal swabs were sampled on the first and the last day of hospitalization. Medical staff and environment were also sampled. Rectal and environmental swabs were immediately plated onto Drigalski agar supplemented with 3 mg/liter of ceftriaxon. Results: Fecal carriage was detected in 21.2% of 244 infants on admission and 57.1% of 154 on discharge, after more than 48 hours of hospitalization (p < 0.001). The species most frequently detected on admission were Escherichia coli and Klebsiella pneumoniae (36.9%), whereas, on discharge, K. pneumoniae was the species most frequently detected (52.7%). ESBL-associated resistances were related to trimethoprim-sulfamethoxazole (91.3%), gentamicin (76.1%), ciprofloxacin (50.0%), but not to amikacin and imipenem. The increased prevalence of carriage during hospitalization was related to standard antimicrobial therapy. Conclusion: The significant emergence of multidrug-resistant enteric pathogens in Malagasy hospitals poses a serious health threat requiring the implementation of surveillance and control measures for nosocomial infections.
引用
收藏
页数:8
相关论文
共 31 条
[11]   Asymptomatic carriage of Klebsiella pneumoniae producing extended-spectrum β-lactamase by patients in a neurological early rehabilitation unit:: Management of an outbreak [J].
Holländer, R ;
Ebke, M ;
Barck, H ;
von Pritzbuer, E .
JOURNAL OF HOSPITAL INFECTION, 2001, 48 (03) :207-213
[12]  
JARLIER V, 1988, REV INFECT DIS, V10, P867
[13]   Fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals [J].
Kader, Abdulrahman Abdulla ;
Kumar, Angamuthu ;
Kamath, Katapadi Ananthkrishna .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (09) :1114-1116
[14]   Minimizing potential resistance: A population dynamics view [J].
Levin, BR .
CLINICAL INFECTIOUS DISEASES, 2001, 33 :S161-S169
[15]   Antimicrobial use and antimicrobial resistance: A population perspective [J].
Lipsitch, M ;
Samore, MH .
EMERGING INFECTIOUS DISEASES, 2002, 8 (04) :347-354
[16]   BETA-LACTAMASES IN LABORATORY AND CLINICAL RESISTANCE [J].
LIVERMORE, DM .
CLINICAL MICROBIOLOGY REVIEWS, 1995, 8 (04) :557-&
[17]  
Mirelis B, 2003, EMERG INFECT DIS, V9, P1024
[18]   Countrywide spread of community- and hospital-acquired extended-spectrum β-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon [J].
Moubareck, C ;
Daoud, Z ;
Hakimé, NI ;
Hamzé, M ;
Mangeney, N ;
Matta, H ;
Mokhbat, JE ;
Rohban, R ;
Sarkis, DK ;
Doucet-Populaire, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (07) :3309-3313
[19]   A between-species comparison of antimicrobial resistance in enterobacteria in fecal flora [J].
Österblad, M ;
Hakanen, A ;
Manninen, R ;
Leistevuo, T ;
Peltonen, R ;
Meurman, O ;
Huovinen, P ;
Kotilainen, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1479-1484
[20]   Editorial response:: Extended-spectrum β-lactamases:: A call for improved detection and control [J].
Paterson, DL ;
Yu, VL .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (06) :1419-1422